Erratum to: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease (Nature Neuroscience, (2018), 21, 10, (1482-1492), 10.1038/s41593-018-0223-0);Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease

Nature Neuroscience

Volumn 21, Issue 10, 2018, Pages 1482-1492

  Dong, Xianjun ^a   Liao, Zhixiang ^a   Gritsch, David ^a   Hadzhiev, Yavor ^b   Bai, Yunfei ^a,c   Locascio, Joseph J ^a,d   Guennewig, Boris ^e,f,g   Liu, Ganqiang ^a   Blauwendraat, Cornelis ^h   Wang, Tao ^a   Adler, Charles H ⁱ   Hedreen, John C ^j   Faull, Richard L M ^k   Frosch, Matthew P ^d   Nelson, Peter T ^l   Rizzu, Patrizia ^h   Cooper, Antony A ^f,g   Heutink, Peter ^h   Beach, Thomas G ^m   Mattick, John S ^f,g   Müller, Ferenc ^b   Scherzer, Clemens R ^a,d,j   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c SOUTHEAST UNIVERSITY   (China)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

^f GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

ⁱ MAYO CLINIC   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF AUCKLAND   (New Zealand)

^l UNIVERSITY OF KENTUCKY   (United States)

^m SUN HEALTH RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ACCURACY; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; COHORT ANALYSIS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; EPIGENETICS; EXON; FEMALE; GENE MAPPING; GENETIC VARIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MICROSCOPY; NONHUMAN; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RNA SEQUENCE; SUBSTANTIA NIGRA PARS COMPACTA; ANIMAL; BRAIN; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHYSIOLOGY; QUANTITATIVE TRAIT LOCUS; ZEBRA FISH;

ANIMALS; BRAIN; DOPAMINERGIC NEURONS; ENHANCER ELEMENTS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; MALE; MENTAL DISORDERS; QUANTITATIVE TRAIT LOCI; ZEBRAFISH;

EID: 85053703429     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/s41593-018-0277-z     Document Type: Erratum

References (80)

1. Cookson, W., Liang, L., Abecasis, G., Moffatt, M. & Lathrop, M. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10, 184–194 (2009)
2. Birney, E. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799–816 (2007). ENCODE Project Consortium et al
3. Heintzman, N. D. et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108–112 (2009)
4. Kowal, S. L., Dall, T. M., Chakrabarti, R., Storm, M. V. & Jain, A. The current and projected economic burden of Parkinson’s disease in the United States. Mov. Disord. 28, 311–318 (2013)
5. Cloutier, M. et al. The economic burden of schizophrenia in the United States in 2013. J. Clin. Psychiatry 77, 764–771 (2016)
6. National Institute of Drug Abuse. Treatment Statistics. DrugAbuse.gov https://www.drugabuse.gov/sites/default/files/drugfacts_treatmentstats.pdf (2011)
7. Hassan, A. & Benarroch, E. E. Heterogeneity of the midbrain dopamine system. Neurology 85, 1795–1805 (2015)
8. Zheng, B. et al. PGC-1α, a potential therapeutic target for early intervention in Parkinson’s disease. Sci. Transl. Med. 2, 52ra73 (2010)
9. Liang, W. S. et al. Neuronal gene expression in non-demented individuals with intermediate Alzheimer’s disease neuropathology. Neurobiol. Aging. 31, 549–566 (2010)
10. Elstner, M. et al. Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions. Mol. Brain 4, 43 (2011)
11. Djebali, S. et al. Landscape of transcription in human cells. Nature 489, 101–108 (2012)
12. Kim, T.-K. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182–187 (2010)
13. Andersson, R. et al. An atlas of active enhancers across human cell types and tissues. Nature 507, 455–461 (2014)
14. Core, L. J. et al. Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers. Nat. Genet. 46, 1311–1320 (2014)
15. Thurman, R. E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75–82 (2012)
16. Heintzman, N. D. et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39, 311–318 (2007)
17. Visel, A. et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854–858 (2009)
18. Yip, K. Y. et al. Classification of human genomic regions based on experimentally determined binding sites of more than 100 transcription-related factors. Genome. Biol. 13, R48 (2012)
19. Engström, P. G., Fredman, D. & Lenhard, B. Ancora: a web resource for exploring highly conserved noncoding elements and their association with developmental regulatory genes. Genome. Biol. 9, R34 (2008)
20. Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015)
21. Akbarian, S. et al. The PsychENCODE project. Nat. Neurosci. 18, 1707–1712 (2015)
22. Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC-seq: A method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 1–9 (2015)
23. Mittal, S. et al. β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease. Science 357, 891–898 (2017)
24. Scherzer, C. R. et al. GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein. Proc. Natl. Acad. Sci. USA. 105, 10907–10912 (2008)
25. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012)
26. Ernst, J. & Kellis, M. ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods 9, 215–216 (2012)
27. Ellingsen, S. et al. Large-scale enhancer detection in the zebrafish genome. Development 132, 3799–3811 (2005)
28. Visel, A., Minovitsky, S., Dubchak, I. & Pennacchio, L. A. VISTA Enhancer Browser–a database of tissue-specific human enhancers. Nucleic Acids Res. 35, D88–D92 (2007)
29. Welter, D. et al. The NHGRI GWAS catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42, D1001–D1006 (2014)
30. Jiang, Y. et al. A genetic screen to assess dopamine receptor (DopR1) dependent sleep regulation in Drosophila. G3 (Bethesda) 6, 4217–4226 (2016)
31. 4 receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biol. 10, e1001347 (2012)
32. Breen, D. P. et al. Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol. 71, 589–595 (2014)
33. Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353–1358 (2012)
34. Nica, A. C. et al. Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. PLoS Genet. 6, e1000895 (2010)
35. Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat. Genet. 46, 989–993 (2014)
36. Wu, H. et al. Tissue-specific RNA expression marks distant-acting developmental enhancers. PLoS Genet. 10, e1004610 (2014)
37. Mercer, E. M. et al. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity 35, 413–425 (2011)
38. Ostuni, R. et al. Latent enhancers activated by stimulation in differentiated cells. Cell 152, 157–171 (2013)
39. Koolen, D. A. et al. Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nat. Genet. 44, 639–641 (2012)
40. Li, R. et al. Six novel susceptibility loci for early-onset androgenetic alopecia and their unexpected association with common diseases. PLoS Genet. 8, e1002746 (2012)
41. Adams, H. H. H. et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat. Neurosci. 19, 1569–1582 (2016)
42. Torsney, K. M. et al. Bone health in Parkinson’s disease: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 85, 1159–1166 (2014)
43. Ding, H. et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology 81, 1531–1537 (2013)
44. Saliba, A. E., Westermann, A. J., Gorski, S. A. & Vogel, J. Single-cell RNA-seq: advances and future challenges. Nucleic Acids Res. 42, 8845–8860 (2014)
45. Lake, B. B. et al. Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain. Science 352, 1586–1590 (2016)
46. Lee, J. H. et al. Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues. Nat. Protoc. 10, 442–458 (2015)
47. Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181–184 (1992)
48. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. Neurobiol. Aging. 18 Suppl, S1–S2 (1997)
49. Bonanni, L., Thomas, A., Onofrj, M. & McKeith, I. G. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 66, 1455 (2006). author reply 1455
50. Schroeder, A. et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol. Biol. 7, 3 (2006)
51. Unni, V. K., Ebrahimi-Fakhari, D., Vanderburg, C. R., McLean, P. J. & Hyman, B. T. Studying protein degradation pathways in vivo using a cranial window-based approach. Methods 53, 194–200 (2011)
52. Ingelsson, M. et al. No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer’s disease brain. Acta Neuropathol. 112, 439–449 (2006)
53. Liu, G. et al. Metal exposure and Alzheimer’s pathogenesis. J. Struct. Biol. 155, 45–51 (2006)
54. Kurn, N. et al. Novel isothermal, linear nucleic acid amplification systems for highly multiplexed applications. Clin. Chem. 51, 1973–1981 (2005)
55. Faherty, S. L., Campbell, C. R., Larsen, P. A. & Yoder, A. D. Evaluating whole transcriptome amplification for gene profiling experiments using RNA-seq. BMC Biotechnol. 15, 65 (2015)
56. Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015)
57. Delaneau, O., Zagury, J.-F. & Marchini, J. Improved whole-chromosome phasing for disease and population genetic studies. Nat. Methods 10, 5–6 (2013)
58. Marchini, J. & Howie, B. Genotype imputation for genome-wide association studies. Nat. Rev. Genet. 11, 499–511 (2010)
59. Anvar, S. Y. et al. Determining the quality and complexity of next-generation sequencing data without a reference genome. Genome. Biol. 15, 555 (2014)
60. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009)
61. Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578 (2012)
62. ’t Hoen, P. A. C. et al. Reproducibility of high-throughput mRNA and small RNA sequencing across laboratories. Nat. Biotechnol. 31, 1015–1022 (2013)
63. Leek, J. T. & Storey, J. D. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 3, 1724–1735 (2007)
64. Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118–127 (2007)
65. Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760–1774 (2012)
66. Zhao, Y. et al. NONCODE 2016: an informative and valuable data source of long non-coding RNAs. Nucleic Acids Res. 44 D1, D203–D208 (2016)
67. Micallef, L. & Rodgers, P. eulerAPE: drawing area-proportional 3-Venn diagrams using ellipses. PLoS One 9, e101717 (2014)
68. Wang, J. et al. Factorbook. org: a Wiki-based database for transcription factor-binding data generated by the ENCODE consortium. Nucleic Acids Res. 41, (D171–D176 (2013)
69. Pollard, K. S., Hubisz, M. J., Rosenbloom, K. R. & Siepel, A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 20, 110–121 (2010)
70. MacArthur, J. et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 45 D1, D896–D901 (2017)
71. Johnson, A. D. et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24, 2938–2939 (2008)
72. Untergasser, A. et al. Primer3–new capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012)
73. Meng, A., Tang, H., Ong, B. A., Farrell, M. J. & Lin, S. Promoter analysis in living zebrafish embryos identifies a cis-acting motif required for neuronal expression of GATA-2. Proc. Natl. Acad. Sci. USA. 94, 6267–6272 (1997)
74. Wen, L. et al. Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish. Dev. Biol. 314, 84–92 (2008)
75. Piñero, J. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 45 D1, D833–D839 (2017)
76. Mathelier, A. et al. JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 44 D1, D110–D115 (2016)
77. Grant, C. E., Bailey, T. L. & Noble, W. S. FIMO: scanning for occurrences of a given motif. Bioinformatics 27, 1017–1018 (2011)
78. Takahashi, H., Lassmann, T., Murata, M. & Carninci, P. 5′ end-centered expression profiling using cap-analysis gene expression and next-generation sequencing. Nat. Protoc. 7, 542–561 (2012)
79. Lassmann, T., Hayashizaki, Y. & Daub, C. O. TagDust–a program to eliminate artifacts from next generation sequencing data. Bioinformatics 25, 2839–2840 (2009)
80. Aguet, F. et al. Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017)